当前位置:产品中心 > 抗体 > Biosimilar抗体 > 细胞因子 > Anti-IL17A hIgG1 Reference Antibody (Secubio)
Anti-IL17A hIgG1 Reference Antibody (Secubio)
基本信息

产品编号:GM-87353MAB

产品名称:Anti-IL17A hIgG1 Reference Antibody (Secubio)

目录价:询价

产品配图.jpg


规格货号

GM-87353MAB-1mg / 1 mg

GM-87353MAB-5mg / 5 mg

GM-87353MAB-25mg / 25 mg

GM-87353MAB-50mg / 50mg

GM-87353MAB-100mg / 100 mg



产品简介

Expression System     CHO

Aggregation               < 5% as determined by SEC-HPLC

Purity                          > 95% as determined by SDS-PAGE

Endotoxin                   < 1 EU/mg, determined by LAL gel clotting assay

Sterility                       0.2 μm Filtered

Target                            IL17A

Clone                             Secukinumab

Alternative Names   CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17

Source/Isotype           Human IgG1(REEM), Kappa

Application                  /

Description                   This gene is a member of the IL-17 receptor family which includes five members (IL-17RA-E) and the encoded protein is a proinflammatory cytokine produced by activated T cells. IL-17A-mediated downstream pathways induce the production of inflammatory molecules, chemokines, antimicrobial peptides, and remodeling proteins. The encoded protein elicits crucial impacts on host defense, cell trafficking, immune modulation, and tissue repair, with a key role in the induction of innate immune defenses. This cytokine stimulates non-hematopoietic cells and promotes chemokine production thereby attracting myeloid cells to inflammatory sites. This cytokine also regulates the activities of NF-kappaB and mitogen-activated protein kinases and can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). IL-17A plays a pivotal role in various infectious diseases, inflammatory and autoimmune disorders, and cancer. High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.

Formulation               Phosphate-buffered solution, pH 7.4.



数据展示


image.png


image.png


当前位置:产品中心 > 抗体 > Biosimilar抗体 > Anti-IL17A hIgG1 Reference Antibody (Secubio)

Anti-IL17A hIgG1 Reference Antibody (Secubio)
基本信息

产品编号:GM-87353MAB

产品名称:Anti-IL17A hIgG1 Reference Antibody (Secubio)

目录价:询价

产品配图.jpg


规格货号

GM-87353MAB-1mg / 1 mg

GM-87353MAB-5mg / 5 mg

GM-87353MAB-25mg / 25 mg

GM-87353MAB-50mg / 50mg

GM-87353MAB-100mg / 100 mg



产品简介

Expression System     CHO

Aggregation               < 5% as determined by SEC-HPLC

Purity                          > 95% as determined by SDS-PAGE

Endotoxin                   < 1 EU/mg, determined by LAL gel clotting assay

Sterility                       0.2 μm Filtered

Target                            IL17A

Clone                             Secukinumab

Alternative Names   CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17

Source/Isotype           Human IgG1(REEM), Kappa

Application                  /

Description                   This gene is a member of the IL-17 receptor family which includes five members (IL-17RA-E) and the encoded protein is a proinflammatory cytokine produced by activated T cells. IL-17A-mediated downstream pathways induce the production of inflammatory molecules, chemokines, antimicrobial peptides, and remodeling proteins. The encoded protein elicits crucial impacts on host defense, cell trafficking, immune modulation, and tissue repair, with a key role in the induction of innate immune defenses. This cytokine stimulates non-hematopoietic cells and promotes chemokine production thereby attracting myeloid cells to inflammatory sites. This cytokine also regulates the activities of NF-kappaB and mitogen-activated protein kinases and can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). IL-17A plays a pivotal role in various infectious diseases, inflammatory and autoimmune disorders, and cancer. High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.

Formulation               Phosphate-buffered solution, pH 7.4.



数据展示


image.png


image.png


Tel: 400-627-9288
留言咨询
重置
提交
客服
微信
电话
留言
留言咨询
重置
提交